Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MD.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MD.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MB.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MB.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MB.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
unclassifiableORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
unclassifiableENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
unclassifiableENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
unclassifiableNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KS.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KS.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HH.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used